Article
Infection control implications of heterogeneous resistance mechanisms in carbapenem-resistant Enterobacteriaceae (CRE).
Expert review of anti-infective therapy - 1 Jan 2016
Goodman K E, Simner P J, Tamma P D, Milstone A M
Abstract excerpt
The Centers for Disease Control and Prevention (CDC) defines carbapenem-resistant Enterobacteriaceae (CRE) based upon a phenotypic demonstration of carbapenem resistance. However, considerable heterogeneity exists within this definitional umbrella. CRE may mechanistically differ by whether they do or do not produce carbapenemases. Moreover, patients can acquire CRE through multiple pathways: endogenously through...
Topics
- Anti-Bacterial Agents
- Bacterial Proteins
- Carbapenems
- Communicable Disease Control
- Cross Infection
- Enterobacteriaceae
- Enterobacteriaceae Infections
- Epidemiological Monitoring
- Gene Expression
- Gene Transfer, Horizontal
